Published in Lab Business Week, June 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Carl Zeiss.
Report 1: Carl Zeiss MicroImaging GmbH has acquired the equipment business of the US Company Clarient and is therefore strengthening its commitment in the promising field of clinical cancer diagnostics and cancer research. With growing life expectation in the population, the subject of cancer, its diagnosis and treatment is now playing an increasingly important role. Here, the joint use of microscopic techniques and molecular-biological methods is increasing. In every diagnosis of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.